March 26, 2019, Vol 321, No. 12, Pages 1135-1228
The True Cost of Measles Outbreaks During the Postelimination Era
Maria E. Sundaram, MSPH, PHD; L. Beryl Guterman, MSPH; Saad B. Omer, MBBS, MPH, PhD
JAMA. 2019;321(12):1155-1156. doi:10.1001/jama.2019.1506
This Viewpoint reviews measles outbreaks in the United States since the year 2000 attributable to vaccine hesitancy, refusal, and exemption, and specifies the costs to individuals, society, and health systems as a result.